{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:20:17Z","timestamp":1740122417277,"version":"3.37.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T00:00:00Z","timestamp":1669939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s10552-022-01658-8","type":"journal-article","created":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T08:29:45Z","timestamp":1669969785000},"page":"223-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant radiation therapy and health-related quality of life among older women with early-stage endometrial cancer: an analysis using the SEER-MHOS linkage"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5082-4759","authenticated-orcid":false,"given":"Jihye","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin E.","family":"Kent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew F.","family":"Olshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy R.","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel B.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,2]]},"reference":[{"key":"1658_CR1","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1002\/cncr.32802","volume":"126","author":"SJ Henley","year":"2020","unstructured":"Henley SJ, Ward EM, Scott S et al (2020) Annual report to the nation on the status of cancer, part I: national cancer statistics. Cancer 126:2225\u20132249","journal-title":"Cancer"},{"key":"1658_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7\u201330","journal-title":"CA Cancer J Clin"},{"key":"1658_CR3","unstructured":"Cancer stat facts: uterine cancer. Surveillance, epidemiology, and end results program (SEER). National cancer institute"},{"key":"1658_CR4","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2217\/fon.14.192","volume":"10","author":"MA Sheikh","year":"2014","unstructured":"Sheikh MA, Althouse AD, Freese KE et al (2014) USA endometrial cancer projections to 2030: should we be concerned? Future Oncol 10:2561\u20132568","journal-title":"Future Oncol"},{"key":"1658_CR5","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913\u20132921","journal-title":"Cancer Res"},{"key":"1658_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-319-43139-0_2","volume":"943","author":"D Gupta","year":"2017","unstructured":"Gupta D (2017) Clinical behavior and treatment of endometrial cancer. Adv Exp Med Biol 943:47\u201374","journal-title":"Adv Exp Med Biol"},{"key":"1658_CR7","unstructured":"(February 11, 2019) NCCN clinical practice guidelines in oncology\u2014uterine neoplasms"},{"key":"1658_CR8","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC et al (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma. Lancet 355:1404\u20131411","journal-title":"Lancet"},{"key":"1658_CR9","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto VL et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol 92:744\u2013751","journal-title":"Gynecol Oncol"},{"key":"1658_CR10","doi-asserted-by":"publisher","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","volume":"81","author":"CL Creutzberg","year":"2011","unstructured":"Creutzberg CL, Nout RA, Lybeert ML et al (2011) Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma. Int J Radiat Oncol Biol Phys 81:e631\u2013e638","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1658_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375:816\u2013823","journal-title":"Lancet"},{"key":"1658_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","volume":"93","author":"SM de Boer","year":"2015","unstructured":"de Boer SM, Nout RA, J\u00fcrgenliemk-Schulz IM et al (2015) Long-term impact of endometrial cancer diagnosis and treatment on health-related quality of life and cancer survivorship: results from the randomized PORTEC-2 trial. Int J Radiat Oncol Biol Phys 93:797\u2013809","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1658_CR13","unstructured":"NCCN. (2021) NCCN clinical practice guidelines in oncology\u2014older adult oncology"},{"key":"1658_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/jgs.13888","volume":"64","author":"EE Kent","year":"2016","unstructured":"Kent EE, Malinoff R, Rozjabek HM et al (2016) Revisiting the surveillance epidemiology and end results cancer registry and medicare health outcomes survey (SEER-MHOS) linked data resource for patient-reported outcomes research in older adults with cancer. J Am Geriatr Soc 64:186\u2013192","journal-title":"J Am Geriatr Soc"},{"key":"1658_CR15","first-page":"5","volume":"29","author":"A Ambs","year":"2008","unstructured":"Ambs A, Warren JL, Bellizzi KM, Topor M, Haffer SC, Clauser SB (2008) Overview of the SEER\u2013Medicare health outcomes survey linked dataset. Health Care Financ Rev 29:5\u201321","journal-title":"Health Care Financ Rev"},{"key":"1658_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00005650-200208001-00002","volume":"40","author":"JL Warren","year":"2002","unstructured":"Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40:3\u201318","journal-title":"Med Care"},{"key":"1658_CR17","unstructured":"National cancer institute: overview of the SEER program"},{"key":"1658_CR18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00005650-200208001-00007","volume":"40","author":"BA Virnig","year":"2002","unstructured":"Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J (2002) Studying radiation therapy using SEER-Medicare-linked data. Med Care 40:49\u201354","journal-title":"Med Care"},{"key":"1658_CR19","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11136-011-9866-y","volume":"20","author":"AJ Selim","year":"2011","unstructured":"Selim AJ, Rogers W, Qian SX, Brazier J, Kazis LE (2011) A preference-based measure of health: the VR-6D derived from the veterans RAND 12-item health survey. Qual Life Res 20:1337\u20131347","journal-title":"Qual Life Res"},{"key":"1658_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11136-009-9582-z","volume":"19","author":"JA Fleishman","year":"2010","unstructured":"Fleishman JA, Selim AJ, Kazis LE (2010) Deriving SF-12v2 physical and mental health summary scores: a comparison of different scoring algorithms. Qual Life Res 19:231\u2013241","journal-title":"Qual Life Res"},{"key":"1658_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ygyno.2016.12.005","volume":"144","author":"KM Doll","year":"2017","unstructured":"Doll KM, Pinheiro LC, Reeve BB (2017) Pre-diagnosis health-related quality of life, surgery, and survival in women with advanced epithelial ovarian cancer: a SEER-MHOS study. Gynecol Oncol 144:348\u2013353","journal-title":"Gynecol Oncol"},{"key":"1658_CR22","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1200\/JCO.2012.48.2596","volume":"31","author":"VW Setiawan","year":"2013","unstructured":"Setiawan VW, Yang HP, Pike MC et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31:2607\u20132618","journal-title":"J Clin Oncol"},{"key":"1658_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/01.EDE.0000081989.82616.7d","volume":"14","author":"T Sato","year":"2003","unstructured":"Sato T, Matsuyama Y (2003) Marginal structural models as a tool for standardization. Epidemiology 14:680\u2013686","journal-title":"Epidemiology"},{"key":"1658_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.gie.2019.04.236","volume":"90","author":"JY Yang","year":"2019","unstructured":"Yang JY, Webster-Clark M, Lund JL, Sandler RS, Dellon ES, St\u00fcrmer T (2019) Propensity score methods to control for confounding in observational cohort studies: a statistical primer and application to endoscopy research. Gastrointest Endosc 90:360\u2013369","journal-title":"Gastrointest Endosc"},{"key":"1658_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/pds.1231","volume":"15","author":"T St\u00fcrmer","year":"2006","unstructured":"St\u00fcrmer T, Rothman KJ, Glynn RJ (2006) Insights into different results from different causal contrasts in the presence of effect-measure modification. Pharmacoepidemiol Drug Saf 15:698\u2013709","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1658_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/aje\/kwj047","volume":"163","author":"T Kurth","year":"2006","unstructured":"Kurth T, Walker AM, Glynn RJ et al (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163:262\u2013270","journal-title":"Am J Epidemiol"},{"key":"1658_CR27","first-page":"335","volume":"2012","author":"DYAJE Dalton","year":"2012","unstructured":"Dalton DYAJE (2012) A unified approach to measuring the effect size between two groups using SAS. SAS Global Forum 2012:335\u20132012","journal-title":"SAS Global Forum"},{"key":"1658_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 46:399\u2013424","journal-title":"Multivariate Behav Res"},{"key":"1658_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jclinepi.2011.09.008","volume":"65","author":"GA Maglinte","year":"2012","unstructured":"Maglinte GA, Hays RD, Kaplan RM (2012) US general population norms for telephone administration of the SF-36v2. J Clin Epidemiol 65:497\u2013502","journal-title":"J Clin Epidemiol"},{"key":"1658_CR30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/0284186X.2018.1560498","volume":"58","author":"N Zandbergen","year":"2019","unstructured":"Zandbergen N, de Rooij BH, Vos MC et al (2019) Changes in health-related quality of life among gynecologic cancer survivors during the two years after initial treatment: a longitudinal analysis. Acta Oncol 58:790\u2013800","journal-title":"Acta Oncol"},{"key":"1658_CR31","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","volume":"29","author":"RA Nout","year":"2011","unstructured":"Nout RA, van de Poll-Franse LV, Lybeert ML et al (2011) Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol 29:1692\u20131700","journal-title":"J Clin Oncol"},{"key":"1658_CR32","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijrobp.2007.02.040","volume":"69","author":"LV van de Poll-Franse","year":"2007","unstructured":"van de Poll-Franse LV, Mols F, Essink-Bot ML et al (2007) Impact of external beam adjuvant radiotherapy on health-related quality of life for long-term survivors of endometrial adenocarcinoma: a population-based study. Int J Radiat Oncol Biol Phys 69:125\u2013132","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1658_CR33","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ygyno.2012.06.007","volume":"127","author":"LV van de Poll-Franse","year":"2012","unstructured":"van de Poll-Franse LV, Pijnenborg JM, Boll D et al (2012) Health related quality of life and symptoms after pelvic lymphadenectomy or radiotherapy vs. no adjuvant regional treatment in early-stage endometrial carcinoma: a large population-based study. Gynecol Oncol 127:153\u2013160","journal-title":"Gynecol Oncol"},{"key":"1658_CR34","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1245\/s10434-014-3562-4","volume":"21","author":"S Damast","year":"2014","unstructured":"Damast S, Alektiar K, Eaton A et al (2014) Comparative patient-centered outcomes (health state and adverse sexual symptoms) between adjuvant brachytherapy versus no adjuvant brachytherapy in early stage endometrial cancer. Ann Surg Oncol 21:2740\u20132754","journal-title":"Ann Surg Oncol"},{"key":"1658_CR35","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/IGC.0b013e3182481611","volume":"22","author":"AM Quick","year":"2012","unstructured":"Quick AM, Seamon LG, Abdel-Rasoul M, Salani R, Martin D (2012) Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma. Int J Gynecol Cancer 22:703\u2013708","journal-title":"Int J Gynecol Cancer"},{"key":"1658_CR36","first-page":"3","volume":"2020","author":"L Enewold","year":"2020","unstructured":"Enewold L, Parsons H, Zhao L et al (2020) Updated overview of the SEER-Medicare data: enhanced content and applications. J Natl Cancer Inst Monogr 2020:3\u201313","journal-title":"J Natl Cancer Inst Monogr"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-022-01658-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-022-01658-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-022-01658-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,13]],"date-time":"2023-02-13T23:47:05Z","timestamp":1676332025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-022-01658-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,2]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["1658"],"URL":"https:\/\/doi.org\/10.1007\/s10552-022-01658-8","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2022,12,2]]},"assertion":[{"value":"29 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jennifer L. Lund receives salary support to the University of North Carolina at Chapel Hill from the Center for Pharmacoepidemiology (Current Members: GlaxoSmithKline, UCB BioSciences, Takeda, AbbVie, Boehringer Ingelheim) and from other pharmaceutical companies (AbbVie, Roche). Her spouse was formerly employed by GlaxoSmithKline and previously owned stock in the company. Jihye Park, Erin E. Kent, Chelsea Anderson, Andrew F. Olshan, Wendy R. Brewster, and Hazel B. Nichols have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}